Protagonist Therapeutics

/Protagonist Therapeutics

Protagonist is a clinical development-stage biopharmaceutical company that utilizes a proprietary technology platform to discover and develop novel peptide-based drugs to address significant unmet medical needs.

Symbol

Last Closing Price
$19.81

Shares
2,000,000

Effective Date
October 12, 2017

Underwriters

To view the prospectus for , or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange